ERRATUM: Women with Pre-Eclampsia have an Altered NKG2A and NKG2C Receptor Expression on Peripheral Blood Natural Killer Cells

Authors

  • Nora Bachmayer,

  • Ebba Sohlberg,

  • Yvonne Sundström,

  • Rangeen Rafik Hamad,

  • Louise Berg,

  • Katarina Bremme,

  • Eva Sverremark-Ekström

Errata

This article corrects:

  1. ORIGINAL ARTICLE: Women with Pre-Eclampsia Have an Altered NKG2A and NKG2C Receptor Expression on Peripheral Blood Natural Killer Cells Volume 62, Issue 3, 147–157, Article first published online: 11 August 2009

In the above article,1Figures 1 and 2 were incorrectly presented.

Figure 1.

 Percentage of natural killer cells in healthy or pre-eclamptic pregnancies and blood donors. Percentage of CD56+ CD3 cells was measured ex vivo in healthy pregnant women (= 13) or pre-eclamptic pregnant women (= 16) and healthy blood donors (= 10).

Figure 2.

 Natural killer-cell receptor expression in healthy or pre-eclamptic pregnancies and blood donors. Expression of NKG2A and NKG2C receptors was analyzed ex vivo in healthy pregnant women (= 13) or pre-eclamptic pregnant women (= 16) together with healthy blood donors (= 10). Percentage of (a) NKG2A+ and (b) NKG2C+ CD56+ CD3 cells. Levels (GeoMFI) of NKG2A (c) or NKG2C (d) on CD56+ CD3 cells.

The correct figures are as follows:

We apologise for the errors.

Ancillary